News

UFO Biosciences launches its cell subtyping services

UFO Biosciences is happy to announce the launch of its cell subtyping services. UFO Biosciences offers a unique solution to identify rare cell subtypes in a heterogeneous sample population to drive dedicated R&D.
UFO biosciences

Levels Diagnostics awarded the MIT R&D grant

Levels Diagnostics was awarded the MIT R&D grant by the Provide of South Holland. Together with Omnigen and SG papertronics the consortium will develop a test that can quickly identify early signs of liver damage in patients.
Levels Diagnostics awarded the MIT R&D grant

Cristal Therapeutics and Intravacc announce strategic collaboration to advance novel vaccine platforms

Bilthoven and Maastricht, the Netherlands, 6 January 2021 – Intravacc, a world leader in translational research and development of vaccines, and Cristal Therapeutics, a technology leader in enabling safer and more effective therapeutics, to
cristal-therapeutics-and-intravacc-announce-strategic-collaboration-to-advance-novel-vaccine-platforms

TargED awarded NWO Take-Off Phase II grant for the development of Microlyse - a next-generation thrombolytic clot-busting drug

We are very pleased to announce that The Netherlands Organization for Scientific Research (NWO) has granted the Take-Off Phase II loan (€250.000) for the further development of our lead compound, Microlyse.
TargED awarded NWO Take-Off Phase II grant for the development of Microlyse - a next-generation thrombolytic clot-busting drug

The Winner of the Venture Challenge Fall 2020 is SLAM Orthopedic!

This year’s winners of the Venture Challenge were uniquely announced in front of an online audience at the Dutch Life Sciences Conference.
The Winner of the Venture Challenge Fall 2020 is SLAM Orthopedic!

The Winner of the Venture Challenge Summer 2020 is PacingCure!

This year’s winners of the Venture Challenge were uniquely announced in front of an online audience at the Dutch Life Sciences Conference.
The Winner of the Venture Challenge Summer 2020 is PacingCure!

UNIIQ invests €200,000 in Venture Challenge winner BIMINI Biotech

BIMINI Biotech, an innovative therapeutics startup that develops new cancer drugs, has secured an investment of €200,000 from proof-of-concept fund UNIIQ to further develop its technology.
UNIIQ invests €200,000 in Venture Challenge winner BIMINI Biotech

Venture Challenge alumni TargED closes seed investment

TargED (formerly IOVA) closes seed investment and partners with UMC Utrecht for the development of Microlyse - a next-generation thrombolytic clot-busting drug  TargED Biopharmaceuticals, a biotech spin-
Venture Challenge alumni TargED closes seed investment

Venture Challenge alumnus Toxys is selected as one of the FD Gazelles of 2020

Toxys is very proud to announce that they been selected as one of the FD Gazelles of 2020.
Venture Challenge alumnus Toxys is selected as one of the FD Gazelles of 2020

GlycoCheck has been named one of the Top 10 Diabetes Care Solution Providers in 2020 by MedTech Outlook

“With its commitment to enhancing treatment options for the most urgent medical needs, GlycoCheck and Microvascular Health Solutions is moving the needle in microvascular health and ensuring quality care for all,” reported MedTech Outlook 
GlycoCheck has been named one of the Top 10 Diabetes Care Solution Providers in 2020 by MedTech Outlook